CANNAINVESTOR Magazine U.S. Publicly Traded June 2019 | Page 186

You can easily look up how pretty much everyone predicted that legalization of cannabis Federally was long off if ever at all. And that is only going back three years whereas we rebutted that argument directly in the pages of CannaInvestor even dismissing published content in mainstay sources such as Forbes.

Since that time more states have legalized and if Illinois is not a game changer (an Ecoforming event) then what is? The Farm Bill is here. GW Pharma’s formulation is legal.

I would be shocked if one of the two presidential candidates either does not include rescheduling as an election promise or does not do during their first term of office. Assuming that happen, what does that mean to the typical retail investor?

Things do not move fast in Washington as we know and in fact perhaps even slower when the branches of government are not in synch. But I would be willing to wager the worse case scenario would indeed be 2024 with a high probability of sooner than 2024. But even when the day happens a lot happens first internally.

The Consolidation curve cannot be avoided. Canada, by example, has around 160 holders of cultivation licenses … that’s it … for the whole country. Canada’s population is similar to that of California where there are thousands of licensed cannabis cultivators/producers. We will see unprecedented upsizing and scaling through M&A for a period of time within states as well as nationwide. All the while, Canada will continue to dominate internationally. Some early players in the USA have already foreseen this; for example, Constellation brands effectively has shares, rights, warrants, and options in Canopy Growth to bring its voting control to over 50%. What a poison pill should some other large multinational player even think of a run at Canopy. Aurora Cannabis must be looking to expand into the US one would suspect.

186